Details of the Drug
General Information of Drug (ID: DMXYWD7)
| Drug Name |
FARNESYL
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
FARNESYL; (6E,10E)-2,6,10-trimethyldodeca-2,6,10-triene; 2,6E,10E-Trimethyl-2,6,10-dodecatriene; CHEBI:36534; 2,6,10-trimethyldodeca-2,6,10-triene; 2,6,10-Farnesatriene; AC1L9FQ4; CHEBI:42362; LMFA11000034; (2E)-3,7,11-Trimethyl-2,6,10-dodecatriene; (6E)-3,7,11-Trimethyl-2,6,10-dodecatriene; (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatriene; (6E,10E)-2,6,10-trimethyl-dodeca-2,6,10-triene
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 206.37 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 0 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


